We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $1.85M
1-Year Est. Return 176.16%
This Fund
S&P 500
This Quarter Est. Return
+294.99%
1 Year Est. Return
+176.16%
3 Year Est. Return
+511.75%
5 Year Est. Return
+854.95%
10 Year Est. Return
+8,566.11%
AUM
$72.5M
AUM Growth
+$48.6M
Cap. Flow
+$9.17M
Cap. Flow %
12.66%
Top 10 Hldgs %
98.3%
Holding
24
New
4
Increased
12
Reduced
1
Closed
6

Top Buys

Rank Stock Value
1
AGRX
Agile Therapeutics
AGRX
+$9.06M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1M
3
CSW
CSW Industrials
CSW
+$350K
4
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
+$250K
5
DOV icon
Dover
DOV
+$197K

Top Sells

Rank Stock Value
1
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
+$688K
2
NSL
NUVEEN SENIOR INCM FD
NSL
+$418K
3
PHD
Pioneer Floating Rate Fund
PHD
+$321K
4
FRA icon
BlackRock Floating Rate Income Strategies Fund
FRA
+$287K
5
JRO
Nuveen Floating Rate Income Opportunty Fund
JRO
+$258K

Sector Composition

Rank Sector Weight
1 Miscellaneous 74.53%
2 Healthcare 20.36%
3 Financials 4.34%
4 Industrials 0.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$818B
$27.8M 38.34%
135,186
+97,935
+263% +$19.1M
CPXX
2
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
$25.6M 35.36%
2,322,769
+76,300
+3% +$250K
AGRX
3
DELISTED
Agile Therapeutics
AGRX
$8.87M 12.24%
714
+702
+5,850% +$9.06M
MDGL icon
4
Madrigal Pharmaceuticals
MDGL
$12.5B
$5.21M 7.19%
620,138
+227
+0% +$1.9K
BRK.B icon
5
Berkshire Hathaway Class B
BRK.B
$1.09T
$1.29M 1.78%
9,116
+7,570
+490% +$1M
ACAS
6
DELISTED
American Capital Ltd
ACAS
$1.04M 1.44%
68,537
-84
-0.1% -$1.17K
IWM icon
7
PUT
iShares Russell 2000 ETF
IWM
$81B
$591K 0.82%
+5,338
New +$553K
CSW
8
CSW Industrials
CSW
$4.98B
$344K 0.47%
+10,906
New +$350K
SCM icon
9
Stellus Capital Investment Corp
SCM
$248M
$240K 0.33%
23,489
+2,109
+10% +$19.1K
ICMB icon
10
Investcorp Credit Management BDC
ICMB
$12.3M
$237K 0.33%
28,418
+13,293
+88% +$111K
KPTI icon
11
Karyopharm Therapeutics
KPTI
$40.1M
$221K 0.31%
+1,655
New +$183K
DOV icon
12
Dover
DOV
$25.7B
$211K 0.29%
+4,067
New +$197K
PFX icon
13
PhenixFIN
PFX
$89.1M
$179K 0.25%
1,355
+520
+62% +$66.5K
ABUS icon
14
Arbutus Biopharma
ABUS
$1.01B
$173K 0.24%
41,903
+12,141
+41% +$43.4K
CDTX
15
DELISTED
Cidara Therapeutics
CDTX
$163K 0.22%
641
– –
ACSF
16
DELISTED
American Capital Senior Floating, Ltd.
ACSF
$155K 0.21%
15,457
+2,300
+17% +$20.5K
ASMB icon
17
Assembly Biosciences
ASMB
$736M
$111K 0.15%
1,849
+341
+23% +$22.8K
MDGL icon
18
CALL
Madrigal Pharmaceuticals
MDGL
$12.5B
$16K 0.02%
1,914
+143
+8% +$1.19K
FRA icon
19
BlackRock Floating Rate Income Strategies Fund
FRA
$387M
– –
-22,285
Closed -$287K
PHD
20
DELISTED
Pioneer Floating Rate Fund
PHD
– –
-29,603
Closed -$321K
NSL
21
DELISTED
NUVEEN SENIOR INCM FD
NSL
– –
-72,363
Closed -$418K
SRRA
22
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
– –
-1,143
Closed -$688K
MDLY
23
DELISTED
Medley Management Inc
MDLY
– –
-3,289
Closed -$187K
JRO
24
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
– –
-26,314
Closed -$258K

Similar funds

1IC
1922 Investment Company Houston, Texas $1.89M AUM 15.39% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $1.91M AUM 81.42% 1-Year Est. Return
HGCK
HPC Germany & Co KG Potsdam, Germany $1.68M AUM 15.3% 1-Year Est. Return
CA
Cohalo Advisory Snoqualmie, Washington $1.65M AUM 11.44% 1-Year Est. Return
CAM
Creekmur Asset Management Morton, Illinois $2.07M AUM
FLC
Fifth Lane Capital Austin, Texas $1.63M AUM 7.3% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $1.56M AUM 25.68% 1-Year Est. Return
DCM
Dupont Capital Management Wilmington, Delaware $2.18M AUM 50.81% 1-Year Est. Return

Caxton Corporation's Q1 2016 Portfolio in Review

As of Q1 2016, Caxton Corporation held 24 positions worth $72.5M, up 204% from $23.8M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

Caxton Corporation deployed $9.17M of net new capital in Q1 2016, opening 4 new positions and adding to 12 existing holdings. Its largest new stake was CSW Industrials: 10,906 shares worth $344K.

By sector, the portfolio is most concentrated in Miscellaneous at 75% of assets, up from 54% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was American Capital Ltd, an estimated $1.17K trimmed.

  • Caxton Corporation's largest Q1 2016 buy was CSW Industrials: 10,906 shares worth $344K.
  • Caxton Corporation added most to Agile Therapeutics in Q1 2016, an estimated $9.06M increase.
  • Caxton Corporation's biggest Q1 2016 reduction was American Capital Ltd, cutting an estimated $1.17K.
  • Caxton Corporation fully exited Sierra Oncology, Inc. Common Stock in Q1 2016, selling an estimated $688K.
  • Caxton Corporation's ten largest holdings make up 98% of its $72.5M portfolio in Q1 2016.
  • Caxton Corporation opened 4 new positions and closed 6 in Q1 2016.
  • Caxton Corporation's portfolio value rose 204% quarter-over-quarter to $72.5M.

Based on Caxton Corporation's 13F filing for Q1 2016, filed 16 May 2016.